Found: 22
Select item for more details and to access through your institution.
Validation of a multivariable prediction model for post‐engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.
- Published in:
- Mycoses, 2019, v. 62, n. 5, p. 418, doi. 10.1111/myc.12891
- By:
- Publication type:
- Article
Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 3, p. 227, doi. 10.1007/s40261-019-00881-7
- By:
- Publication type:
- Article
Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 5, p. 724, doi. 10.1111/ejh.13604
- By:
- Publication type:
- Article
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 138, doi. 10.1111/ejh.13417
- By:
- Publication type:
- Article
Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain.
- Published in:
- Journal of Clinical Apheresis, 2021, v. 36, n. 4, p. 612, doi. 10.1002/jca.21901
- By:
- Publication type:
- Article
Biomarker-driven phase Ib clinical trial of OPB-111077 in acute myeloid leukemia.
- Published in:
- Medicine International (2754-3242), 2022, v. 2, n. 2, p. 1, doi. 10.3892/mi.2022.32
- By:
- Publication type:
- Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00835-5
- By:
- Publication type:
- Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00835-5
- By:
- Publication type:
- Article
Single-Nucleotide Polymorphism Array-Based Karyotyping of Acute Promyelocytic Leukemia.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0100245
- By:
- Publication type:
- Article
Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 672, doi. 10.1111/bjh.16432
- By:
- Publication type:
- Article
FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients—efficacy and microbiologic safety.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07702-5
- By:
- Publication type:
- Article
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2267, doi. 10.3390/cancers15082267
- By:
- Publication type:
- Article
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 438, doi. 10.3390/cancers15020438
- By:
- Publication type:
- Article
Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5799, doi. 10.3390/cancers14235799
- By:
- Publication type:
- Article
Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1921, doi. 10.3390/cancers14081921
- By:
- Publication type:
- Article
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.
- Published in:
- Disease Markers, 2022, p. 1, doi. 10.1155/2022/3132941
- By:
- Publication type:
- Article
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
Copper deficiency: a cause of misdiagnosis of myelodysplastic syndrome.
- Published in:
- 2018
- By:
- Publication type:
- case study
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin.
- Published in:
- 2017
- By:
- Publication type:
- journal article